Affluent Medical SA (FR:AFME) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Affluent Medical SA, a French medical technology company, is set to participate in several key scientific conferences in Q4 2024, aiming to showcase their innovative implantable medical devices for heart diseases and urinary incontinence. The company has reported progress in its medical devices, including a partnership with Edward Lifesciences and promising clinical trial results. With the goal of commercial launch by 2025/early 2026, Affluent Medical is advancing towards pivotal studies and approvals in their mission to improve patient care.
For further insights into FR:AFME stock, check out TipRanks’ Stock Analysis page.